Lifecore Biomedical Inc.
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $7.4103
- Today's High:
- $7.57
- Open Price:
- $7.47
- 52W Low:
- $1.52
- 52W High:
- $11.46
- Prev. Close:
- $7.47
- Volume:
- 139866
Company Statistics
- Market Cap.:
- $232.27 million
- Book Value:
- 1.128
- Revenue TTM:
- $173.39 million
- Operating Margin TTM:
- -11.31%
- Gross Profit TTM:
- $50.37 million
- Profit Margin:
- -67.8%
- Return on Assets TTM:
- -4.36%
- Return on Equity TTM:
- -80.13%
Company Profile
Lifecore Biomedical Inc. had its IPO on 1996-02-15 under the ticker symbol LFCR.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Lifecore Biomedical Inc. has a staff strength of 0 employees.
Stock update
Shares of Lifecore Biomedical Inc. opened at $7.47 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $7.41 - $7.57, and closed at $7.55.
This is a +1.07% increase from the previous day's closing price.
A total volume of 139,866 shares were traded at the close of the day’s session.
In the last one week, shares of Lifecore Biomedical Inc. have slipped by -4.07%.
Lifecore Biomedical Inc.'s Key Ratios
Lifecore Biomedical Inc. has a market cap of $232.27 million, indicating a price to book ratio of 2.5263 and a price to sales ratio of 1.1682.
In the last 12-months Lifecore Biomedical Inc.’s revenue was $173.39 million with a gross profit of $50.37 million and an EBITDA of $607000. The EBITDA ratio measures Lifecore Biomedical Inc.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Lifecore Biomedical Inc.’s operating margin was -11.31% while its return on assets stood at -4.36% with a return of equity of -80.13%.
In Q1.6666666666667, Lifecore Biomedical Inc.’s quarterly earnings growth was a positive 0% while revenue growth was a negative 26.2%.
Lifecore Biomedical Inc.’s PE and PEG Ratio
- Forward PE
- 35.0877
- Trailing PE
- 0
- PEG
- 3.513
Its diluted EPS in the last 12-months stands at $-2.3 per share while it has a forward price to earnings multiple of 35.0877 and a PEG multiple of 3.513. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Lifecore Biomedical Inc.’s profitability.
Lifecore Biomedical Inc. stock is trading at a EV to sales ratio of 2.1205 and a EV to EBITDA ratio of -17.5662. Its price to sales ratio in the trailing 12-months stood at 1.1682.
Lifecore Biomedical Inc. stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $236.15 million
- Total Liabilities
- $37.67 million
- Operating Cash Flow
- $6.39 million
- Capital Expenditure
- $6.14 million
- Dividend Payout Ratio
- 0%
Lifecore Biomedical Inc. ended 2024 with $236.15 million in total assets and $0 in total liabilities. Its intangible assets were valued at $236.15 million while shareholder equity stood at $34.21 million.
Lifecore Biomedical Inc. ended 2024 with $0 in deferred long-term liabilities, $37.67 million in other current liabilities, 30000.00 in common stock, $-140091000.00 in retained earnings and $13.88 million in goodwill. Its cash balance stood at $2.95 million and cash and short-term investments were $2.95 million. The company’s total short-term debt was $1,455,000 while long-term debt stood at $98.96 million.
Lifecore Biomedical Inc.’s total current assets stands at $88.44 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $32.37 million compared to accounts payable of $14.76 million and inventory worth $48.70 million.
In 2024, Lifecore Biomedical Inc.'s operating cash flow was $6.39 million while its capital expenditure stood at $6.14 million.
Comparatively, Lifecore Biomedical Inc. paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $7.55
- 52-Week High
- $11.46
- 52-Week Low
- $1.52
- Analyst Target Price
- $10
Lifecore Biomedical Inc. stock is currently trading at $7.55 per share. It touched a 52-week high of $11.46 and a 52-week low of $11.46. Analysts tracking the stock have a 12-month average target price of $10.
Its 50-day moving average was $9.46 and 200-day moving average was $6.97 The short ratio stood at 5.61 indicating a short percent outstanding of 0%.
Around 275.2% of the company’s stock are held by insiders while 7776.5% are held by institutions.
Frequently Asked Questions About Lifecore Biomedical Inc.
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is based in Chaska, Minnesota.